Development Level

Tchem 4 | 1,890
Tbio 2 | 10,625
Tclin 2 | 602

Disease

Cancer 7 | 2,346
medulloblastoma, large-cell 6 | 6,234
osteosarcoma 6 | 7,933
psoriasis 6 | 6,685
Liver disease 5 | 219
intraductal papillary-mucinous neoplasm (IPMN) 5 | 3,289
pancreatic ductal adenocarcinoma liver metastasis 5 | 1,795
Adverse reaction to drug 4 | 54
Drug-Induced Liver Injury 4 | 118
Prostatic Neoplasms 4 | 471
Lung Neoplasms 3 | 171
Precursor Cell Lymphoblastic Leukemia Lymphoma 3 | 42
diabetes mellitus 3 | 1,663
glioblastoma 3 | 5,572
intraductal papillary-mucinous adenoma (IPMA) 3 | 2,956
lung carcinoma 3 | 2,844
ovarian cancer 3 | 8,484
tuberculosis 3 | 1,557
Adenocarcinoma 2 | 115
Colorectal Neoplasms 2 | 217
Coronary artery disease 2 | 240
Coumarin Resistance 2 | 4
Drug allergy 2 | 36
Epilepsy 2 | 346
Hepatitis C 2 | 90
Liver Neoplasms, Experimental 2 | 48
Liver neoplasms 2 | 109
Mammary Neoplasms 2 | 410
Neural Tube Defects 2 | 27
Schizophrenia 2 | 501
Vascular disease 2 | 281
adult high grade glioma 2 | 2,148
atypical teratoid / rhabdoid tumor 2 | 4,369
group 3 medulloblastoma 2 | 2,254
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
nervous system disorder 2 | 53
pancreatic cancer 2 | 2,300
pilocytic astrocytoma 2 | 3,086
primitive neuroectodermal tumor 2 | 3,031
ulcerative colitis 2 | 2,087
Acute kidney injury 1 | 65
Alcohol dependence 1 | 107
Alcoholic Intoxication, Chronic 1 | 41
Animal Mammary Neoplasms 1 | 136
Articular gout 1 | 11
Atrophic 1 | 10
Autoimmune hepatitis 1 | 13
Autoimmune polyendocrine syndrome 1 | 6
Brain Diseases 1 | 22
Brain Neoplasms 1 | 23
Carcinoma, Small Cell 1 | 8
Cardiomegaly 1 | 66
Cardiomyopathies 1 | 90
Cardiovascular system disease 1 | 194
Chronic Obstructive Airway Disease 1 | 47
Diarrhea 1 | 155
Drug Eruptions 1 | 18
Esophageal candidiasis 1 | 3
Exanthem 1 | 39
Fatty Liver 1 | 48
Fatty liver disease 1 | 84
Gout 1 | 93
Growth Disorders 1 | 33
Heart Diseases 1 | 42
Heart failure 1 | 80
Hemorrhage 1 | 18
Hepatomegaly 1 | 10
Human immunodeficiency virus infectious disease 1 | 92
Hyperuricemia 1 | 35
Infarction, Middle Cerebral Artery 1 | 25
Ischemia 1 | 27
Kidney Diseases 1 | 86
Leber congenital amaurosis 1 | 72
Leukopenia 1 | 42
Liver Cirrhosis, Experimental 1 | 108
Liver Diseases, Parasitic 1 | 9
Liver diseases 1 | 66
Lung Injury 1 | 20
Lymphoma, Non-Hodgkin 1 | 22
Major Depressive Disorder 1 | 106
Mammary Neoplasms, Experimental 1 | 150
Methemoglobinemia 1 | 17
Micronuclei, Chromosome-Defective 1 | 19
Nasopharyngeal Neoplasms 1 | 8
Necrosis 1 | 51
Neoplasm Invasiveness 1 | 127
Nerve Degeneration 1 | 73
Neutropenia 1 | 78
Nicotine dependence 1 | 53
Opisthorchiasis 1 | 14
Osteonecrosis 1 | 25
Pain agnosia 1 | 99
Parkinson Disease 1 | 102
Pulmonary Embolism 1 | 45
Pulmonary emphysema 1 | 34
Squamous cell carcinoma 1 | 94
Squamous cell carcinoma of esophagus 1 | 82
Substance abuse 1 | 55
Thrombocytopenia 1 | 105
Urinary bladder cancer 1 | 31

Tissue

Blood and immune system 8 | 17,995
Cardiovascular System 8 | 17,958
Digestive Tract 8 | 18,473
Endocrine System 8 | 18,512
Female tissues 8 | 18,647
Liver and Pancreas 8 | 18,136
Male tissues 8 | 17,969
Nervous System 8 | 18,561
Respiratory system 8 | 17,484
Skin and soft tissues 8 | 18,115
Urinary Tract 8 | 18,444

Target Family

Non-IDG 5 | 11,971
Enzyme 3 | 4,146

PathwayCommons: smpdb Pathway

Caffeine Metabolism 8 | 8
Phenytoin (Antiarrhythmic) Act... 79 | 79
Lidocaine (Antiarrhythmic) Act... 61 | 61
Carvedilol Action Pathway 60 | 60
Labetalol Action Pathway 60 | 60
Muscle/Heart Contraction 60 | 60
Acebutolol Action Pathway 59 | 59
Alprenolol Action Pathway 59 | 59
Amiodarone Action Pathway 59 | 59
Amlodipine Action Pathway 59 | 59
Arbutamine Action Pathway 59 | 59
Atenolol Action Pathway 59 | 59
Betaxolol Action Pathway 59 | 59
Bevantolol Action Pathway 59 | 59
Bisoprolol Action Pathway 59 | 59
Bopindolol Action Pathway 59 | 59
Bupranolol Action Pathway 59 | 59
Carteolol Action Pathway 59 | 59
Diltiazem Action Pathway 59 | 59
Disopyramide Action Pathway 59 | 59
Dobutamine Action Pathway 59 | 59
Epinephrine Action Pathway 59 | 59
Esmolol Action Pathway 59 | 59
Felodipine Action Pathway 59 | 59
Flecainide Action Pathway 59 | 59
Fosphenytoin (Antiarrhythmic) ... 59 | 59
Ibutilide Action Pathway 59 | 59
Isoprenaline Action Pathway 59 | 59
Isradipine Action Pathway 59 | 59
Levobunolol Action Pathway 59 | 59
Metipranolol Action Pathway 59 | 59
Metoprolol Action Pathway 59 | 59
Mexiletine Action Pathway 59 | 59
Nadolol Action Pathway 59 | 59
Nebivolol Action Pathway 59 | 59
Nifedipine Action Pathway 59 | 59
Nimodipine Action Pathway 59 | 59
Nisoldipine Action Pathway 59 | 59
Nitrendipine Action Pathway 59 | 59
Oxprenolol Action Pathway 59 | 59
Penbutolol Action Pathway 59 | 59
Pindolol Action Pathway 59 | 59
Practolol Action Pathway 59 | 59
Procainamide (Antiarrhythmic) ... 59 | 59
Propranolol Action Pathway 59 | 59
Quinidine Action Pathway 59 | 59
Sotalol Action Pathway 59 | 59
Timolol Action Pathway 59 | 59
Tocainide Action Pathway 59 | 59
Verapamil Action Pathway 59 | 59
Azathioprine Action Pathway 47 | 47
Ibuprofen Action Pathway 47 | 47
Mercaptopurine Action Pathway 47 | 47
Thioguanine Action Pathway 47 | 47
Warburg Effect 45 | 45
Intracellular Signalling Throu... 38 | 38
AICA-Ribosiduria 37 | 37
Adenine phosphoribosyltransfer... 37 | 37
Adenosine Deaminase Deficiency 37 | 37
Adenylosuccinate Lyase Deficie... 37 | 37
Gout or Kelley-Seegmiller Synd... 37 | 37
Intracellular Signalling Throu... 37 | 37
Lesch-Nyhan Syndrome (LNS) 37 | 37
Mitochondrial DNA depletion sy... 37 | 37
Molybdenum Cofactor Deficiency 37 | 37
Myoadenylate deaminase deficie... 37 | 37
Purine Metabolism 37 | 37
Purine Nucleoside Phosphorylas... 37 | 37
Xanthine Dehydrogenase Deficie... 37 | 37
Xanthinuria type I 37 | 37
Xanthinuria type II 37 | 37
Fc Epsilon Receptor I Signalin... 36 | 36
Morphine Action Pathway 35 | 35
Retinol Metabolism 35 | 35
Vitamin A Deficiency 35 | 35
Celecoxib Action Pathway 34 | 34
Eplerenone Action Pathway 33 | 33
Spironolactone Action Pathway 33 | 33
Amiloride Action Pathway 32 | 32
Bendroflumethiazide Action Pat... 32 | 32
Blue diaper syndrome 32 | 32
Bumetanide Action Pathway 32 | 32
Chlorothiazide Action Pathway 32 | 32
Chlorthalidone Action Pathway 32 | 32
Cyclothiazide Action Pathway 32 | 32
Cystinuria 32 | 32
Ethacrynic Acid Action Pathway 32 | 32
Furosemide Action Pathway 32 | 32
Glucose Transporter Defect (SG... 32 | 32
Hartnup Disorder 32 | 32
Hydrochlorothiazide Action Pat... 32 | 32
Hydroflumethiazide Action Path... 32 | 32
Iminoglycinuria 32 | 32
Indapamide Action Pathway 32 | 32
Kidney Function 32 | 32
Lysinuric Protein Intolerance 32 | 32
Lysinuric protein intolerance ... 32 | 32
Methyclothiazide Action Pathwa... 32 | 32
Metolazone Action Pathway 32 | 32
Polythiazide Action Pathway 32 | 32
Quinethazone Action Pathway 32 | 32

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Arylamine N-acetyltransferase 2 NAT2 Tchem Enzyme -2.71360 546.9 245
Xanthine dehydrogenase/oxidase XDH Tclin Enzyme -2.66145 485.9 150
Cytochrome P450 2A6 CYP2A6 Tchem Non-IDG -2.81123 676.8 221
Cytochrome P450 2C8 CYP2C8 Tbio Non-IDG -2.50903 331.1 134
Cytochrome P450 2C9 CYP2C9 Tchem Non-IDG -3.17625 1560.3 155
Cytochrome P450 3A4 CYP3A4 Tclin Enzyme -3.62253 4494.0 323
Cytochrome P450 2E1 CYP2E1 Tbio Non-IDG -3.38706 2573.0 350
Cytochrome P450 1A2 CYP1A2 Tchem Non-IDG -3.30248 2022.5 420